Sneak Preview: R&D Investments Must Focus On India’s Competitive Advantages
This article was originally published in PharmAsia News
Executive Summary
India has unique capabilities for genomic databases, translational research and nanotechnology, which should spur research on cancer leads, according to a BCG report to be released May 11.